Insulinemia and pancreatic alpha2-adrenoceptors in salt-sensitive (SBH) and salt-resistant (SBN) Sabra rats: effect of high salt diet.
Studies in humans have suggested that hyperinsulinemia might play an important role in salt sensitivity and in the later development of high blood pressure. This possibility has been tested in this study on Sabra rats, an animal model of salt-induced hypertension. Salt-sensitive (SBH) and salt-resistant (SBN) Sabra rats have been submitted to either a normal (0.2% NaCl) or a high salt (8% NaCl) diet for 6 weeks. Comparisons of blood pressure, basal glucose and insulin levels, and insulin response to glucose overload (1 g/kg) have been made. As pancreatic alpha2-adrenergic receptors are implicated in the control of insulin release, their densities have been determined on plasma membranes by saturation studies with [3H]-RX-821002 as the specific radioligand. Under normal diet, blood pressures were respectively 133 +/- 9 and 108 +/- 10 mm Hg (n = 6) in SBH and SBN. Basal glucose and insulin levels and insulin response to glucose overload were found to be significantly higher in SBH than in SBN. In contrast, alpha2-adrenergic receptor densities were lower (P < .001) in SBH when compared to SBN. High salt diet increased (P < .01) blood pressure, decreased basal glucose (P < .01) and insulin (P < .001) levels only in SBH. However, when compared to SBN the insulin response to glucose overload was maintained higher in SBH. Alpha2-adrenergic receptor densities and difference between SBH and SBN did not differ from those found in normal diet. In conclusion, the salt-induced high blood pressure of salt-sensitive Sabra rats is not associated with hyperinsulinemia and insulin resistance. Indeed, an improvement in the insulin sensitivity appears to be induced by either a high salt diet or high blood pressure.
Ilhami
N
N
CJF Inserm 94.02, Service de Biochimie de Paris-Quest, UFR Biomédicale des Saints-Pères, Paris, France.
Giudicelli
Y
Y
Dausse
J P
JP
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004195:Disease Models, Animal; D006946:Hyperinsulinism / Q000097:blood*; D006973:Hypertension / Q000097:blood* / Q000139:chemically induced; D007328:Insulin / Q000097:blood; D008297:Male; D010179:Pancreas / Q000737:chemistry / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects / Q000378:metabolism*; D012982:Sodium, Dietary / Q000008:administration & dosage; D014280:Triglycerides / Q000097:blood
D001786:Blood Glucose; D007328:Insulin; D018341:Receptors, Adrenergic, alpha-2; D012982:Sodium, Dietary; D014280:Triglycerides